Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Will the Mental Health Clinical Trials Market Evolve in Terms of Growth and Size by 2029?
The market size for mental health clinical trials has seen robust growth in the recent past. There will be growth from $2.96 billion in 2024 to $3.23 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. This growth in the previous period can be tied to the growing interest in the development of neuropsychiatric drugs, increasing incidences of stress, anxiety and depression, heightened support from government and regulatory agencies, a growing elderly population, and an increased demand for non-pharmacological interventions.
In the upcoming years, the market size of mental health clinical trials is predicted to witness significant growth, escalating to $4.51 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. This surge during the forecast period can be credited to the increasing incidence of mental health disorders, heightened awareness about mental health problems, the rising demand for treatments tailored to the individual, escalated healthcare expenses, and a growing reliance on digital health technologies. Noteworthy trends in this forecast period encompass advancements in digital health systems, technological improvements in wearable devices, progression in neuroimaging technologies, enhancements in electronic data capture (EDC) systems, and the rise of technology-driven decentralized clinical trial models.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27343&type=smp
What factors are expected to fuel Mental Health Clinical Trials market growth in the coming years?
The increasing occurrence of mental health conditions is anticipated to drive the expansion of the mental health clinical trials market in the future. Mental health conditions are identified as ailments which considerably influence an individual’s emotional state, thought processes, conduct, and overall psychological health. These disorders are proliferating due to the escalating stress resulting from contemporary lifestyles, which include job stress, social estrangement, and perpetual digital engagement. Mental health clinical tests play a significant role in refining care as they assess the safety and efficacy of new medications, therapies, and behavioural techniques for mental health disorders. As an example, the American Psychiatric Association, a non-profit organisation based in the US, reported in May 2024 that approximately 43% of American adults were experiencing heightened levels of anxiety in 2024, an upward trend from 37% in 2023 and 32% in 2022. Consequently, the escalating occurrence of mental health conditions is fueling the expansion of the mental health clinical trials market.
What Are The Key Findings From The Segmentation Analysis Of The Mental Health Clinical Trials Market?
The mental health clinical trials market covered in this report is segmented
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Interventional, Observational, Other Study Designs
3) By Disorder: Anxiety Disorders, Depression, Bipolar Affective Disorder, Dissociation And Dissociative Disorders, Schizophrenia, Other Disorders
4) By Sponsor: Pharmaceutical And Biopharmaceutical Companies, Government Agencies, Other Sponsors
Subsegments:
1) By Phase I: Single Ascending Dose, Multiple Ascending Dose, First In Human, Pharmacokinetics Studies
2) By Phase II: Dose Ranging Studies, Proof Of Concept Studies, Randomized Controlled Trials, Open Label Studies
3) By Phase III: Large Scale Randomized Trials, Multicenter Studies, Comparative Effectiveness Trials, Double Blind Studies
4) By Phase IV: Post Marketing Surveillance, Long Term Safety Studies, Real World Evidence Studies, Pharmacovigilance Studies
Which Trends Are Expected To Shape The Future Of The Mental Health Clinical Trials Market?
Leading firms in the mental health clinical trials market are prioritizing the development of superior treatments, like adjunctive therapies, to increase their efficiency, improve patient outcomes, and fulfil unmet needs in mental health disorders. Adjunctive therapies are drugs used alongside main treatments to increase their effectiveness in treating complicated conditions. For example, in December 2022, AbbVie Inc., an American biopharmaceutical enterprise, obtained approval from the U.S. Food and Drug Administration (FDA) for VRAYLAR (cariprazine) to be used as an adjunctive treatment for major depressive disorder in adults. VRAYLAR provides an innovative partial dopamine-serotonin agonist mechanism that supplements mainstream antidepressants. It aids in alleviating depressive symptoms in patients who do not adequately respond to standard therapy. Furthermore, the product also aids in mood stabilization while minimizing the side effects commonly experienced with older antipsychotics.
What Are The Most Active Companies In The Mental Health Clinical Trials Market Today?
Major companies operating in the mental health clinical trials market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials, Inc., Ergomed, Celerion Inc., Biotrial S.A.S., Lindus Health Ltd., Novotech Health Holdings Pte Ltd., Precision for Medicine Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report
Which Regional Markets Are Attracting The Most Investment In Mental Health Clinical Trials?
North America was the largest region in the mental health clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27343&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model